These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8767301

  • 1. [Disorders of lipid metabolism--diagnosis and therapy in general practice. 7: Treatment of increased triglycerides].
    Richter WO.
    Fortschr Med; 1996 Jun 20; 114(17):229-30. PubMed ID: 8767301
    [No Abstract] [Full Text] [Related]

  • 2. [Disorders of lipid metabolism--diagnosis and therapy in general practice. 6: Different forms of hypertriglyceridemia].
    Richter W.
    Fortschr Med; 1996 Jun 10; 114(16):211-2. PubMed ID: 8767932
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Severe hypertriglyceridemia].
    Heim M, Wertli M.
    Praxis (Bern 1994); 2013 Aug 21; 102(17):1023-32. PubMed ID: 23965715
    [No Abstract] [Full Text] [Related]

  • 5. [Excessive hypertriglyceridemia and pancreatitis in a 17-year-old pregnant patient].
    Scheffler E, Kather H, Schlierf G, Ziegler R.
    Internist (Berl); 1991 Jun 21; 32(6):354-5. PubMed ID: 1880014
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment.
    Vaverkova H, Frohlich J, Jackuliakova D, Novotny D.
    Clin Biochem; 2005 Jun 21; 38(6):509-13. PubMed ID: 15885228
    [Abstract] [Full Text] [Related]

  • 8. Managing the patient with hypertriglyceridemia: a practical approach for nurse practitioners.
    Rankin FM, Cohen JD.
    J Am Acad Nurse Pract; 2008 Dec 21; 20 Suppl 2():1-14; quiz 15. PubMed ID: 19143900
    [No Abstract] [Full Text] [Related]

  • 9. Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.
    Bermúdez-Pirela V, Souki A, Cano-Ponce C, Bermúdez-Arias F, Mengual-Moreno E, Leal-Gonzalez E, Lemus-Antepaz M, de Bravo MC, de Díaz AA, de Pirela NL, Cano-Peñaloza R, Puche-Medina G, Arraiz N, Reyna-Villazmil N, Contreras F, Israili ZH, Valasco M.
    Am J Ther; 2007 Dec 21; 14(2):213-20. PubMed ID: 17414592
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia.
    Sheu WH, Jeng CY, Lee WJ, Lin SY, Pei D, Chen YT.
    Metabolism; 2001 Mar 21; 50(3):355-9. PubMed ID: 11230791
    [Abstract] [Full Text] [Related]

  • 11. [Hypertriglyceridemia].
    Hübel K, Suter PM.
    Praxis (Bern 1994); 2009 Jun 24; 98(13):677-81; quiz 682-3. PubMed ID: 19551651
    [No Abstract] [Full Text] [Related]

  • 12. [1,5-dicoffeechinic acid in the treatment of hypertriglyceridemia].
    Wojcicki J, Olejak B, Pieczul-Mróz J, Torbus-Lisiecka B, Bukowska H, Gregorczyk J.
    Przegl Lek; 1982 Jun 24; 39(9):601-6. PubMed ID: 6897455
    [No Abstract] [Full Text] [Related]

  • 13. Chylomicronemia syndrome.
    Chait A, Brunzell JD.
    Adv Intern Med; 1992 Jun 24; 37():249-73. PubMed ID: 1557997
    [Abstract] [Full Text] [Related]

  • 14. Chylomicronemia and the chylomicronemia syndrome: a practical approach to management.
    Leaf DA.
    Am J Med; 2008 Jan 24; 121(1):10-2. PubMed ID: 18187065
    [Abstract] [Full Text] [Related]

  • 15. [Drug therapy of dyslipidemias].
    Fonda M, Cattin L, Guarnieri G.
    Recenti Prog Med; 2000 Jan 24; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract] [Full Text] [Related]

  • 16. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW.
    Curr Med Res Opin; 2001 Jan 24; 17(1):60-73. PubMed ID: 11464448
    [Abstract] [Full Text] [Related]

  • 17. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2009 Aug 15; 104(4):548-53. PubMed ID: 19660610
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
    Yeshurun D, Hamood H, Morad N, Naschitz J.
    Harefuah; 2000 Apr 16; 138(8):650-3, 710. PubMed ID: 10883206
    [Abstract] [Full Text] [Related]

  • 20. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
    Christidis DS, Liberopoulos EN, Kakafika AI, Miltiadous GA, Cariolou M, Ganotakis ES, Mikhailidis DP, Elisaf MS.
    J Cardiovasc Pharmacol Ther; 2006 Sep 16; 11(3):211-21. PubMed ID: 17056835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.